繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
立即開戶
CVS Health | 8-K: Current report
CVS Health | 8-K: Current report
西維斯健康 | 8-K:重大事件
牛牛AI助理已提取核心訊息
CVS Health announced early results and pricing of its maximum tender offer for up to $1.77 billion of senior notes across multiple series. The tender offer received strong response with over $5.2 billion in aggregate principal amount tendered by the December 13 early tender deadline.Based on the tender results, CVS Health will accept for purchase notes with acceptance priority levels 1-4 in full, and level 5 notes at a 57.5% proration factor. The total consideration ranges from $685.54 to $825.77 per $1,000 principal amount for accepted notes. Settlement for accepted notes is expected on December 18, 2024.Due to the strong early participation exceeding the maximum tender amount, no additional notes will be accepted after the early tender deadline. The offer was part of CVS Health's ongoing liability management initiatives targeting various series of outstanding senior notes with maturities from 2030 to 2050.
CVS Health announced early results and pricing of its maximum tender offer for up to $1.77 billion of senior notes across multiple series. The tender offer received strong response with over $5.2 billion in aggregate principal amount tendered by the December 13 early tender deadline.Based on the tender results, CVS Health will accept for purchase notes with acceptance priority levels 1-4 in full, and level 5 notes at a 57.5% proration factor. The total consideration ranges from $685.54 to $825.77 per $1,000 principal amount for accepted notes. Settlement for accepted notes is expected on December 18, 2024.Due to the strong early participation exceeding the maximum tender amount, no additional notes will be accepted after the early tender deadline. The offer was part of CVS Health's ongoing liability management initiatives targeting various series of outstanding senior notes with maturities from 2030 to 2050.
西維斯健康宣佈了其最高招標要約的早期結果和定價,涉及多系列的高級票據,最高金額爲17.7億美金。招標要約反響強烈,截至12月13日的早期招標截止日期,累計招標金額超過52億美金。根據招標結果,西維斯健康將完全接受優先級爲1-4的票據,優先級爲5的票據將按57.5%的比例接受。接受的票據總考慮金額爲每1,000美金本金685.54至825.77美金。接受票據的結算預計在2024年12月18日進行。由於強勁的早期參與超出了最高招標金額,在早期招標截止日期之後將不再接受其他票據。此次要約是西維斯健康正在進行的負債管理舉措的一部分,針對的是2030年至2050年到期的各系列未償還高級票據。
西維斯健康宣佈了其最高招標要約的早期結果和定價,涉及多系列的高級票據,最高金額爲17.7億美金。招標要約反響強烈,截至12月13日的早期招標截止日期,累計招標金額超過52億美金。根據招標結果,西維斯健康將完全接受優先級爲1-4的票據,優先級爲5的票據將按57.5%的比例接受。接受的票據總考慮金額爲每1,000美金本金685.54至825.77美金。接受票據的結算預計在2024年12月18日進行。由於強勁的早期參與超出了最高招標金額,在早期招標截止日期之後將不再接受其他票據。此次要約是西維斯健康正在進行的負債管理舉措的一部分,針對的是2030年至2050年到期的各系列未償還高級票據。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
資訊熱榜
更新時間